About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Blood Cancer Diagnostics Market Size, Trends & Share by 2033

Blood Cancer Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Blood tests., Biopsy, Imaging tests, Molecular tests), By Product (Instruments, Assay kits & reagents), By End-User (Hospitals, Specialty clinics, Diagnostic Centers, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI56867DR
Author : Debashree Bora

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Blood Cancer Diagnostics Market Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Blood tests.
        1. By Value
      3. Biopsy
        1. By Value
      4. Imaging tests
        1. By Value
      5. Molecular tests
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Assay kits & reagents
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Specialty clinics
        1. By Value
      4. Diagnostic Centers
        1. By Value
      5. Others
        1. By Value
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Blood tests.
        1. By Value
      3. Biopsy
        1. By Value
      4. Imaging tests
        1. By Value
      5. Molecular tests
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Assay kits & reagents
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Specialty clinics
        1. By Value
      4. Diagnostic Centers
        1. By Value
      5. Others
        1. By Value
    5. U.S.
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Blood tests.
          1. By Value
        3. Biopsy
          1. By Value
        4. Imaging tests
          1. By Value
        5. Molecular tests
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Assay kits & reagents
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Specialty clinics
          1. By Value
        4. Diagnostic Centers
          1. By Value
        5. Others
          1. By Value
    6. Canada
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Blood tests.
        1. By Value
      3. Biopsy
        1. By Value
      4. Imaging tests
        1. By Value
      5. Molecular tests
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Assay kits & reagents
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Specialty clinics
        1. By Value
      4. Diagnostic Centers
        1. By Value
      5. Others
        1. By Value
    5. U.K.
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Blood tests.
          1. By Value
        3. Biopsy
          1. By Value
        4. Imaging tests
          1. By Value
        5. Molecular tests
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Assay kits & reagents
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Specialty clinics
          1. By Value
        4. Diagnostic Centers
          1. By Value
        5. Others
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Blood tests.
        1. By Value
      3. Biopsy
        1. By Value
      4. Imaging tests
        1. By Value
      5. Molecular tests
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Assay kits & reagents
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Specialty clinics
        1. By Value
      4. Diagnostic Centers
        1. By Value
      5. Others
        1. By Value
    5. China
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Blood tests.
          1. By Value
        3. Biopsy
          1. By Value
        4. Imaging tests
          1. By Value
        5. Molecular tests
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Assay kits & reagents
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Specialty clinics
          1. By Value
        4. Diagnostic Centers
          1. By Value
        5. Others
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Blood tests.
        1. By Value
      3. Biopsy
        1. By Value
      4. Imaging tests
        1. By Value
      5. Molecular tests
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Assay kits & reagents
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Specialty clinics
        1. By Value
      4. Diagnostic Centers
        1. By Value
      5. Others
        1. By Value
    5. UAE
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Blood tests.
          1. By Value
        3. Biopsy
          1. By Value
        4. Imaging tests
          1. By Value
        5. Molecular tests
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Assay kits & reagents
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Specialty clinics
          1. By Value
        4. Diagnostic Centers
          1. By Value
        5. Others
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Blood tests.
        1. By Value
      3. Biopsy
        1. By Value
      4. Imaging tests
        1. By Value
      5. Molecular tests
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Assay kits & reagents
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Specialty clinics
        1. By Value
      4. Diagnostic Centers
        1. By Value
      5. Others
        1. By Value
    5. Brazil
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Blood tests.
          1. By Value
        3. Biopsy
          1. By Value
        4. Imaging tests
          1. By Value
        5. Molecular tests
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Assay kits & reagents
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Specialty clinics
          1. By Value
        4. Diagnostic Centers
          1. By Value
        5. Others
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Blood Cancer Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Abbott
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Illumina, Inc
    3. Bio-Rad Laboratories, Inc.
    4. Quest Diagnostics Incorporated
    5. Invivoscribe, Inc.
    6. Adaptive Biotechnologies
    7. SOPHiA GENETICS.
    8. SkylineDx
    9. Bio-Techne
    10. QIAGEN
    11. Alercell
    12. Danaher Corporation
    13. Hoffmann-La Roche Ltd  
    14. Myriad Genetics Inc.
    15. NeoGenomics Laboratories
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer
Straits Research - Access Portal
  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Get Free Access


We are featured on :

www.straitsresearch.com
© Copyright . All rights Reserved.